Stat proteins control lymphocyte proliferation by regulating p27(Kip1) expression

Molecular and Cellular Biology

Volumn 18, Issue 4, 1998, Pages 1996-2003

  Kaplan, Mark H ^a,d   Daniel, Carla ^c   Schindler, Ulrike ^c   Grusby, Michael J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AMGEN INC   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; INTERLEUKIN 4; PROTEIN P27; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0031948848     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.4.1996     Document Type: Article

References (67)

1. Kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:4327-4336.
2. Kip1 cyclin-depcndent kinase inhibitor expression during IL-4 mediated human B cell activation. J. Immunol. 158:3054-3061.
3. Broome, H. E., C. M. Dargan, S. Krajewski, and J. C. Reed. 1995. Expression of bcl-2, bcl-x and bax after T cell activation and IL-2 withdrawal. J. Immunol. 155:2311-2317.
4. Brugarolos, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Lacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
5. Carlesso, N., D. A. Frank, and J. D. Griffen. 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183:811-820.
6. Waf1/Cip1 mediated by Stat1. Science 272:719-722.
7. Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
8. Danial, N. N., A. Pernis, and P. B. Rothman. 1995. Jak-Stat signaling induced by the v-abl oncogene. Science 269:1875-1877.
9. Cip1/Waf1 undergo normal development, but are detective in G1 checkpoint control. Cell 82:675-684.
10. Deng, G., and E. R. Podack. 1993. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2 mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. USA 90:2189-2193.
11. Deutsch, H. H. J., K. Koettnitz, J. Chung, and F. S. Kalthoff. 1995. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth control. J. Immunol. 154:3696-3703.
12. Dokter, W. H., P. Borger, D. Hendricks, I. van der Horst, M. R. Halie, and E. Vellenga. 1992. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional levels. Blood 80:2721-2728.
13. Kip1-deficient mice. Cell 85:733-744.
14. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889-4901.
15. Fujii, H., Y. Nakagawa, U. Schindler, A. Kawahara, H. Mori, F. Gouilleux, B. Groner, J. N. Ihle, Y. Minami, and T. Miyazaki. 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92:5482-5486.
16. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822-2830.
17. Hengst, L., and S. I. Reed. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864.
18. Hilton. D. J., J.-G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Wilson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497-501.
19. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho., M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706.
20. Johnston, J. A., M. Kawamura, R. A. Kirken, Y.-Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153.
21. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313-319.
22. Kaplan, M. H., Y.-L. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177.
23. Keegan, A. D., K. Nelms, M. White, L.-M. Wang, J. H. Pierce, and W. E. Paul. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-1 phosphorylation and cell growth. Cell 76:811-820.
24. Kip1. Cell 85:721-732.
25. Klemsz, M. J., L. B. Justement, E. Palmer, and J. C. Cambier. 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143:1032-1039.
26. Kip1 in splenic B cells activated by surface Ig cross-linking. J. Immunol. 158:2050-2056.
27. Kondo, M., T. Takeshita, M. Higuchi, M. Nakamura, T. Sudo, S.-I. Nishikawa, and K. Sugamura. 1994. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263:1453-1454.
28. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262: 1265-1267.
29. Kip1 expression following the polyclonal activation of murine Go T cells. J. Immunol. 158:5642-5648.
30. Kip1. Mol. Cell. Biol. 16:6744-6751.
31. WAF1/Cip1 by STAT5. Mol. Cell. Biol. 17:2933-2943.
32. Cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
33. Meur, S. C., and K. H. M. zum Buschenfelde. 1986. T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to proliferation. J. Immunol. 136:4106-4112.
34. Migone, T.-S., J.-X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-Stat pathway in T cells transformed with HTLV-I. Science 269:79-81.
35. Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272:7093-7098.
36. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, and T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-1047.
37. Miyazaki T., Z.-J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Perlmutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81:223-231.
38. Mui, A. L.-F., H. Wakao, T. Kinoshita, T. Kitamura, and A. Miyajima. 1996. Suppression of interleukin-3-induced gene expression by a c-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15:2425-2433.
39. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85:707-720.
40. Noguchi, M., Y. Nakamura, S. M. Russell, S. F. Ziegler, M. Tsang, X. Cao, and W. J. Leonard. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262:1877-1880.
41. Kip1 cyclin-depcndent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
42. Pagano M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteosome pathway in regulating the abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
43. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
44. Pernis, A., B. Witthuhn, A. D. Keegan, K. Nelms, E. Garfein, J. N. Ihle, W. E. Paul, J. H. Pierce, and P. Rothman. 1995. Interleukin 4 signals through two related pathways. Proc. Natl. Acad. Sci. USA 92:7971-7975.
45. Pruett, W., Y. Yuan, E. Rose, A. G. Batzer, N. Harada, and E. Y. Skolnik. 1995. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Mol. Cell. Biol. 15:1778-1785.
46. Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, K. Nelms, W. E. Paul, and J. N. Ihle 1995 Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336-3343.
47. Quelle, F. W., D. Wang, T. Nosaka, W. E. Thierfelder, D. Stravopodis, Y. Weinstein, and J. N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16:1622-1631.
48. Russell, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, A. S. Goldman, F. C. Schmalsteig, J. N. Ihle, J. J. O'Shea, and W. J. Leonard. 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak 3: implications for XSCID and XCID. Science 266:1042-1045.
49. Ryan, J. J., L. J. McReynolds, A. Keegan, L.-H. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123-132.
50. Schindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman. 1994. STF-IL-4: a novel IL-4 induced signal transducing factor. EMBO J. 13:1350-1350.
51. Schindler, U., P. Wu, M. Rothe, M. Brasseur, and S. L. McKnight. 1995. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2:689-697.
52. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
53. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633.
54. Sun, X. L., L.-M. Wang, Y. Zhang, L. Yenush, M. G. J. Myers, E. Glasheen, W. S. Lane, J. H. Pierce, and M. F. White. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177.
55. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, K. Nakanishi, N. Yoshido, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627-630.
56. Takeshita, T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, and K. Sugamura. 1992. Cloning of the gamma chain of the human IL-2 receptor. Science 257:379-382.
57. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. A. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1996. Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature 382:171-174.
58. Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325-330.
59. Wang, D., D. Stravopodis, S. Teglund, J. Kitazawa, and J. N. Ihle. 1996. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16:6141-6148.
60. Wang, H. Y., W. E. Paul, and A. D. Keegan. 1996. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4:113-121.
61. Wang, H. Y., J. Zamorano, J. L. Yoerkie, W. E. Paul, and A. D. Keegan. 1997. The IL-4 induced tyrosine phosphorylation of the insulin receptor substrate is dependent on Jak1 expression in human fibrosarcoma cells. J. Immunol. 158:1037-1040.
62. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983.
63. Yu, C.-L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83.
64. Zamorano, J., H. Y. Wang, L.-M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:4926-4934.
65. Kip1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17:407-415.
66. Kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.
67. Zuber, C. E., J. P. Galizzi, N. Harada, I. Durand, and J. Banchereau. 1990. Interleukin-4 receptors on human blood mononuclear cells. Cell. Immunol. 129:329-340.